Article
Epidermal growth factor receptor mutation in combination with expression of MIG6 alters gefitinib sensitivity.
BMC systems biology - 18 Feb 2011
Naruo Yoshimi, Nagashima Takeshi, Ushikoshi-Nakayama Ryoko, Saeki Yuko, Nakakuki Takashi, Naka Takashi, Tanaka Hiroshi, Tsai Shih-Feng, Okada-Hatakeyama Mariko
Abstract excerpt
BACKGROUND: Epidermal growth factor receptor (EGFR) signaling plays an important role in the regulation of cell proliferation, survival, metastasis, and invasion in various tumors. Earlier studies showed that the EGFR is frequently overexpressed in non-small-cell lung cancer (NSCLC) and EGFR mutations at specific amino acid residues in the kinase domain induce altered responsiveness to gefitinib, a small molecule...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
